当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Boosting delivery of rare disease therapies: the IRDiRC Orphan Drug Development Guidebook.
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2020-04-20 , DOI: 10.1038/d41573-020-00060-w Anneliene Hechtelt Jonker , Virginie Hivert , Michela Gabaldo , Liliana Batista , Daniel O’Connor , Annemieke Aartsma-Rus , Simon Day , Ken Sakushima , Diego Ardigo
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2020-04-20 , DOI: 10.1038/d41573-020-00060-w Anneliene Hechtelt Jonker , Virginie Hivert , Michela Gabaldo , Liliana Batista , Daniel O’Connor , Annemieke Aartsma-Rus , Simon Day , Ken Sakushima , Diego Ardigo
The International Rare Diseases Research Consortium (IRDiRC) has created a Guidebook to facilitate drug development for rare diseases by organizing available tools into a standardized framework.
中文翻译:
促进稀有疾病疗法的交付:《 IRDiRC孤儿药物开发指南》。
国际罕见病研究协会(IRDiRC)已创建指南,通过将可用工具整合到标准化框架中来促进罕见病药物的开发。
更新日期:2020-04-24
中文翻译:
促进稀有疾病疗法的交付:《 IRDiRC孤儿药物开发指南》。
国际罕见病研究协会(IRDiRC)已创建指南,通过将可用工具整合到标准化框架中来促进罕见病药物的开发。